These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 27420986)
1. Protein-protein interaction between ezrin and p65 in human breast cancer cells. Tang R; Li FX; Shao WF; Wen QS; Yu XR; Xiong JB Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27420986 [TBL] [Abstract][Full Text] [Related]
2. Interaction Between Ezrin and Cortactin in Promoting Epithelial to Mesenchymal Transition in Breast Cancer Cells. He J; Ma G; Qian J; Zhu Y; Liang M; Yao N; Ding Q; Chen L; Liu X; Xia T; Wang S Med Sci Monit; 2017 Apr; 23():1583-1596. PubMed ID: 28364518 [TBL] [Abstract][Full Text] [Related]
3. [Effect of microRNA-mediated p65 gene silencing on the proliferation and apoptosis of human breast cancer MDA-MB-231 cells]. Wang L; Shan BE; Sang MX; Lian YS; Wang B; Ding CY Nan Fang Yi Ke Da Xue Xue Bao; 2011 Oct; 31(10):1742-7. PubMed ID: 22027781 [TBL] [Abstract][Full Text] [Related]
4. Effect of RhoA signaling transduction on expression of Ezrin in breast cancer cell lines. Ma L; Liu YP; Zhang XH; Xing LX; Wang JL; Geng CZ Ai Zheng; 2009 Feb; 28(2):108-11. PubMed ID: 19550117 [TBL] [Abstract][Full Text] [Related]
5. Ezrin and BCAR1/p130Cas mediate breast cancer growth as 3-D spheroids. Konstantinovsky S; Davidson B; Reich R Clin Exp Metastasis; 2012 Aug; 29(6):527-40. PubMed ID: 22476538 [TBL] [Abstract][Full Text] [Related]
6. [Phosphorylation of ezrin Tyr477 is critical in invasion of breast cancer cells stimulated by precursor of nerve growth factor]. Li FX; Shao WF; Tang R; Yu XR; Wen QS; Yu YL; Xiong JB Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jun; 36(7):898-903. PubMed ID: 27435765 [TBL] [Abstract][Full Text] [Related]
7. Ezrin silencing by small hairpin RNA reverses metastatic behaviors of human breast cancer cells. Li Q; Wu M; Wang H; Xu G; Zhu T; Zhang Y; Liu P; Song A; Gang C; Han Z; Zhou J; Meng L; Lu Y; Wang S; Ma D Cancer Lett; 2008 Mar; 261(1):55-63. PubMed ID: 18155831 [TBL] [Abstract][Full Text] [Related]
8. Clinical implications of Ezrin and CD44 co‑expression in breast cancer. Ma L; Jiang T Oncol Rep; 2013 Oct; 30(4):1899-905. PubMed ID: 23900701 [TBL] [Abstract][Full Text] [Related]
9. EPHA7 and EPHA10 Physically Interact and Differentially Co-localize in Normal Breast and Breast Carcinoma Cell Lines, and the Co-localization Pattern Is Altered in EPHB6-expressing MDA-MB-231 Cells. Johnson C; Segovia B; Kandpal RP Cancer Genomics Proteomics; 2016 09-10; 13(5):359-68. PubMed ID: 27566654 [TBL] [Abstract][Full Text] [Related]
10. A conserved region within interferon regulatory factor 5 controls breast cancer cell migration through a cytoplasmic and transcription-independent mechanism. Pimenta EM; Barnes BJ Mol Cancer; 2015 Feb; 14(1):32. PubMed ID: 25649192 [TBL] [Abstract][Full Text] [Related]
11. Podocalyxin increases the aggressive phenotype of breast and prostate cancer cells in vitro through its interaction with ezrin. Sizemore S; Cicek M; Sizemore N; Ng KP; Casey G Cancer Res; 2007 Jul; 67(13):6183-91. PubMed ID: 17616675 [TBL] [Abstract][Full Text] [Related]
12. Atypical ezrin localization as a marker of locally advanced breast cancer. Arslan AA; Silvera D; Arju R; Giashuddin S; Belitskaya-Levy I; Formenti SC; Schneider RJ Breast Cancer Res Treat; 2012 Aug; 134(3):981-8. PubMed ID: 22415480 [TBL] [Abstract][Full Text] [Related]
13. Abnormal ezrin localization is associated with clinicopathological features in invasive breast carcinomas. Sarrió D; Rodríguez-Pinilla SM; Dotor A; Calero F; Hardisson D; Palacios J Breast Cancer Res Treat; 2006 Jul; 98(1):71-9. PubMed ID: 16538541 [TBL] [Abstract][Full Text] [Related]
14. Curcumin blocks RON tyrosine kinase-mediated invasion of breast carcinoma cells. Narasimhan M; Ammanamanchi S Cancer Res; 2008 Jul; 68(13):5185-92. PubMed ID: 18593918 [TBL] [Abstract][Full Text] [Related]
15. Ezrin regulates focal adhesion and invadopodia dynamics by altering calpain activity to promote breast cancer cell invasion. Hoskin V; Szeto A; Ghaffari A; Greer PA; Côté GP; Elliott BE Mol Biol Cell; 2015 Oct; 26(19):3464-79. PubMed ID: 26246600 [TBL] [Abstract][Full Text] [Related]
16. Rad GTPase inhibits the NFκB pathway through interacting with RelA/p65 to impede its DNA binding and target gene transactivation. Hsiao BY; Chang TK; Wu IT; Chen MY Cell Signal; 2014 Jul; 26(7):1437-44. PubMed ID: 24632303 [TBL] [Abstract][Full Text] [Related]
17. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors. Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481 [TBL] [Abstract][Full Text] [Related]
18. [Nanog promotes the invasion of breast cancer cells by increasing PKCε expression]. Shao WF; Li FX; Tang R; Yu XR; Wen QS; Yu YL; Xiong JB Nan Fang Yi Ke Da Xue Xue Bao; 2016 May; 36(5):639-44. PubMed ID: 27222177 [TBL] [Abstract][Full Text] [Related]
19. Osteopontin up-regulates critical epithelial-mesenchymal transition transcription factors to induce an aggressive breast cancer phenotype. Li NY; Weber CE; Mi Z; Wai PY; Cuevas BD; Kuo PC J Am Coll Surg; 2013 Jul; 217(1):17-26; discussion 26. PubMed ID: 23619316 [TBL] [Abstract][Full Text] [Related]
20. [Expression of Ezrin and E-cadherin in invasive ductal breast cancer and their correlations to lymphatic metastasis]. Li Q; Wu MF; Song AP; Wei JC; Xu G; Lu YP; Ma D Ai Zheng; 2006 Mar; 25(3):363-6. PubMed ID: 16536996 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]